Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gribben

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Hemasphere|April 21, 2020
Reducing Bureaucracy in Clinical Research: A Call for ActionJohn Gribben, Elizabeth Macintyre, Pieter Sonneveld, et al.
Haematologica|November 26, 2008
Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphomaDavid Wrench, Rachel Waters, Emanuela Carlotti, et al.
Hemasphere|November 2, 2020
Fair Pricing of Innovative Medicines: An EHA Position PaperAnton Hagenbeek, John Gribben, Ulrich Jäger, et al.
Hemasphere|May 22, 2024
Influence of donor-recipient sex on engraftment of normal and leukemia stem cells in xenotransplantationSyed A Mian, Linda Ariza-McNaughton, Fernando Anjos-Afonso, et al.
Stem Cells Translational Medicine|February 5, 2014
A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanismsEmmanuel Griessinger, Fernando Anjos-Afonso, Irene Pizzitola, et al.
Nature Communications|November 23, 2017
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemiaAlessandro Di Tullio, Kevin Rouault-Pierre, Ander Abarrategi, et al.
Leukemia|December 21, 2018
Single cell analysis of clonal architecture in acute myeloid leukaemiaNicola Potter, Farideh Miraki-Moud, Luca Ermini, et al.
Cancer|July 13, 2006
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemiaStefan Faderl, Kanti Rai, John Gribben, et al.
Blood|January 24, 2013
P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapseSunil Iyengar, Andrew Clear, Csaba Bödör, et al.
British Journal of Haematology|July 29, 2015
Characteristics of human primary mantle cell lymphoma engraftment in NSG miceSunil Iyengar, Linda Ariza-McNaughton, Andrew Clear, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Hemasphere|April 21, 2020
Reducing Bureaucracy in Clinical Research: A Call for ActionJohn Gribben, Elizabeth Macintyre, Pieter Sonneveld, et al.
Haematologica|November 26, 2008
Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphomaDavid Wrench, Rachel Waters, Emanuela Carlotti, et al.
Hemasphere|November 2, 2020
Fair Pricing of Innovative Medicines: An EHA Position PaperAnton Hagenbeek, John Gribben, Ulrich Jäger, et al.
Hemasphere|May 22, 2024
Influence of donor-recipient sex on engraftment of normal and leukemia stem cells in xenotransplantationSyed A Mian, Linda Ariza-McNaughton, Fernando Anjos-Afonso, et al.
Stem Cells Translational Medicine|February 5, 2014
A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanismsEmmanuel Griessinger, Fernando Anjos-Afonso, Irene Pizzitola, et al.
Nature Communications|November 23, 2017
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemiaAlessandro Di Tullio, Kevin Rouault-Pierre, Ander Abarrategi, et al.
Leukemia|December 21, 2018
Single cell analysis of clonal architecture in acute myeloid leukaemiaNicola Potter, Farideh Miraki-Moud, Luca Ermini, et al.
Cancer|July 13, 2006
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemiaStefan Faderl, Kanti Rai, John Gribben, et al.
Blood|January 24, 2013
P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapseSunil Iyengar, Andrew Clear, Csaba Bödör, et al.
British Journal of Haematology|July 29, 2015
Characteristics of human primary mantle cell lymphoma engraftment in NSG miceSunil Iyengar, Linda Ariza-McNaughton, Andrew Clear, et al.
Pageof 11